iShares Core US Aggregate Bond ETF vs GeneDx Holdings Corp — how do they compare? iShares Core US Aggregate Bond ETF trades at $97.32, while GeneDx Holdings Corp trades at $82 (market cap $2.44B). The key difference: GeneDx Holdings Corp is trading nearer its 52-week high, iShares Core US Aggregate Bond ETF nearer its low. Which is the better fit depends on your goals.
| AGG | WGS | |
|---|---|---|
Sector | Fixed Income | Technology |
52-Week High | $101.40 | $167.51 |
52-Week Low | $97.24 | $34.51 |
Market Cap | — | $2.44B |
Enterprise Value | — | $2.48B |
Trailing returns across standard periods
AGG tracks the Bloomberg U.S. Aggregate Bond Index, providing broad exposure to the total U.S. investment-grade bond market. It serves as a core portfolio building block by diversifying across Treasuries, government-related bonds, corporate debt, and mortgage-backed securities.
Read more on AGG →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →